Gene Editing Companies Hit Back at Paper that Criticized CRISPR

Go to article

Posted by on June 9, 2017 5:13 pm
Tags:
Categories: BioMedicine

Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies.

Leave a Reply

Your email address will not be published. Required fields are marked *

< Buzz Post home